LGND
LIGAND PHARMACEUTICALS INCCompany with tickers: LGND, LGNDZ, LGNXZ, LGNYZ, LGNZZ
CIK
886163
CUSIP
53220K504
Shares Outstanding
19,941,141
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-01 | KOZARICH JOHN W | Director | Sell | 146 |
| 2026-04-01 | Reardon Andrew | CLO & Secretary | Sell | 460 |
| 2026-04-01 | Reardon Andrew | CLO & Secretary | Convert | 5,000 |
| 2026-04-01 | Reardon Andrew | CLO & Secretary | Convert | 5,000 |
| 2026-03-23 | Sabba Stephen L | Director | Sell | 1,000 |
| 2026-03-11 | Espinoza Octavio | Chief Financial Officer | Convert | 2,405 |
| 2026-03-11 | Espinoza Octavio | Chief Financial Officer | Convert | 2,405 |
| 2026-03-11 | Espinoza Octavio | Chief Financial Officer | Sell | 3,057 |
| 2026-03-06 | LAMATTINA JOHN L | Director | Sell | 2,161 |
| 2026-03-06 | LAMATTINA JOHN L | Director | Convert | 2,161 |
| 2026-03-06 | LAMATTINA JOHN L | Director | Convert | 2,161 |
| 2026-03-04 | Espinoza Octavio | Chief Financial Officer | Convert | 1,607 |
| 2026-03-04 | Espinoza Octavio | Chief Financial Officer | Sell | 699 |
| 2026-03-04 | Espinoza Octavio | Chief Financial Officer | Convert | 1,607 |
| 2026-03-04 | Reardon Andrew | CLO & Secretary | Convert | 5,000 |
| 2026-03-04 | Reardon Andrew | CLO & Secretary | Sell | 100 |
| 2026-03-04 | Reardon Andrew | CLO & Secretary | Convert | 5,000 |
| 2026-03-03 | Sabba Stephen L | Director | Convert | 2,034 |
| 2026-03-03 | Sabba Stephen L | Director | Sell | 2,034 |
| 2026-03-03 | Sabba Stephen L | Director | Convert | 2,034 |
| 2026-03-02 | Reardon Andrew | CLO & Secretary | Award | 4,513 |
| 2026-03-02 | Reardon Andrew | CLO & Secretary | Award | 21,525 |
| 2026-03-02 | Davis Todd C | Director, Chief Executive Officer | Award | 10,495 |
| 2026-03-02 | Davis Todd C | Director, Chief Executive Officer | Award | 50,058 |
| 2026-03-02 | Espinoza Octavio | Chief Financial Officer | Award | 23,527 |
| 2026-03-02 | Espinoza Octavio | Chief Financial Officer | Award | 4,933 |
| 2026-03-02 | KOZARICH JOHN W | Director | Sell | 47 |
| 2026-02-15 | Espinoza Octavio | Chief Financial Officer | Tax | 1,026 |
| 2026-02-15 | Reardon Andrew | CLO & Secretary | Tax | 593 |
| 2026-02-15 | Davis Todd C | Director, Chief Executive Officer | Tax | 2,039 |
| 2026-02-14 | Espinoza Octavio | Chief Financial Officer | Tax | 3,761 |
| 2026-02-14 | Espinoza Octavio | Chief Financial Officer | Award | 7,390 |
| 2026-02-14 | Reardon Andrew | CLO & Secretary | Tax | 3,211 |
| 2026-02-14 | Reardon Andrew | CLO & Secretary | Award | 6,928 |
| 2026-02-14 | Davis Todd C | Director, Chief Executive Officer | Award | 20,782 |
| 2026-02-14 | Davis Todd C | Director, Chief Executive Officer | Tax | 8,178 |
| 2026-02-02 | KOZARICH JOHN W | Director | Sell | 39 |
| 2026-01-02 | KOZARICH JOHN W | Director | Sell | 21 |
| 2025-12-31 | Espinoza Octavio | Chief Financial Officer | Other | 8 |
| 2025-12-17 | LIGAND PHARMACEUTICALS INC | Director, 10% Owner | Other | 0 |
| 2025-12-17 | LIGAND PHARMACEUTICALS INC | Director, 10% Owner | Award | 0 |
| 2025-12-16 | Espinoza Octavio | Chief Financial Officer | Convert | 1,194 |
| 2025-12-16 | Espinoza Octavio | Chief Financial Officer | Convert | 1,194 |
| 2025-12-12 | Espinoza Octavio | Chief Financial Officer | Sell | 1,804 |
| 2025-12-08 | Aryeh Jason | Director | Convert | 2,034 |
| 2025-12-08 | Aryeh Jason | Director | Convert | 2,034 |
| 2025-12-08 | Aryeh Jason | Director | Other | 51,594 |
| 2025-12-05 | Espinoza Octavio | Chief Financial Officer | Tax | 1,862 |
| 2025-12-04 | Davis Todd C | Director, Chief Executive Officer | Gift | 130 |
| 2025-12-01 | KOZARICH JOHN W | Director | Sell | 92 |
| 2025-11-07 | Gray Nancy Ryan | Director | Convert | 3,556 |
| 2025-11-07 | Gray Nancy Ryan | Director | Sell | 3,556 |
| 2025-11-07 | Gray Nancy Ryan | Director | Convert | 3,556 |
| 2025-11-07 | LAMATTINA JOHN L | Director | Convert | 2,145 |
| 2025-11-07 | LAMATTINA JOHN L | Director | Sell | 2,145 |
| 2025-11-07 | LAMATTINA JOHN L | Director | Convert | 2,145 |
| 2025-11-06 | LIGAND PHARMACEUTICALS INC | Director, 10% Owner | Award | 0 |
| 2025-11-03 | KOZARICH JOHN W | Director | Sell | 84 |
| 2025-10-01 | KOZARICH JOHN W | Director | Sell | 24 |
| 2025-09-23 | Aryeh Jason | Director | Sell | 4,418 |
| 2025-09-23 | Aryeh Jason | Director | Other | 51,594 |
| 2025-09-22 | Zimmermann Martine | Director | Tax | 115 |
| 2025-09-02 | KOZARICH JOHN W | Director | Sell | 267 |
| 2025-08-10 | Reardon Andrew | CLO & Secretary | Tax | 1,325 |
| 2025-08-01 | KOZARICH JOHN W | Director | Sell | 467 |
| 2025-07-10 | KOZARICH JOHN W | Director | Sell | 934 |
| 2025-07-01 | LIGAND PHARMACEUTICALS INC | Director, 10% Owner | Other | 0 |
| 2025-07-01 | LIGAND PHARMACEUTICALS INC | Director, 10% Owner | Other | 15,000 |
| 2025-07-01 | LIGAND PHARMACEUTICALS INC | Director, 10% Owner | Other | 1,500,000 |
| 2025-06-30 | Espinoza Octavio | Chief Financial Officer | Other | 224 |
| 2025-06-30 | Reardon Andrew | CLO & Secretary | Other | 233 |
| 2025-06-30 | Davis Todd C | Director, Chief Executive Officer | Other | 233 |
| 2025-06-23 | Reardon Andrew | CLO & Secretary | Sell | 500 |
| 2025-06-10 | Reardon Andrew | CLO & Secretary | Sell | 500 |
| 2025-06-06 | Aryeh Jason | Director | Other | 51,594 |
| 2025-06-06 | Aryeh Jason | Director | Award | 1,209 |
| 2025-06-06 | Aryeh Jason | Director | Award | 5,783 |
| 2025-06-06 | Sabba Stephen L | Director | Award | 1,209 |
| 2025-06-06 | Sabba Stephen L | Director | Award | 5,783 |
| 2025-06-06 | KOZARICH JOHN W | Director | Award | 1,209 |
| 2025-06-06 | KOZARICH JOHN W | Director | Award | 5,783 |
| 2025-06-06 | Haas Jason | Director | Award | 5,783 |
| 2025-06-06 | Haas Jason | Director | Award | 1,209 |
| 2025-06-06 | Gray Nancy Ryan | Director | Award | 5,783 |
| 2025-06-06 | Gray Nancy Ryan | Director | Award | 1,209 |
| 2025-06-06 | Zimmermann Martine | Director | Tax | 188 |
| 2025-06-06 | Zimmermann Martine | Director | Award | 1,209 |
| 2025-06-06 | Zimmermann Martine | Director | Award | 5,783 |
| 2025-06-06 | LAMATTINA JOHN L | Director | Award | 1,209 |
| 2025-06-06 | LAMATTINA JOHN L | Director | Award | 5,783 |
| 2025-05-15 | Reardon Andrew | CLO & Secretary | Sell | 1,000 |
| 2025-05-09 | Espinoza Octavio | Chief Financial Officer | Buy | 1,000 |
| 2025-05-09 | Davis Todd C | Director, Chief Executive Officer | Buy | 1,680 |
| 2025-04-01 | Sabba Stephen L | Director | Convert | 2,406 |
| 2025-04-01 | Sabba Stephen L | Director | Convert | 2,406 |
| 2025-03-04 | Reardon Andrew | CLO & Secretary | Award | 28,043 |
| 2025-03-04 | Reardon Andrew | CLO & Secretary | Award | 6,415 |
| 2025-03-04 | Davis Todd C | Director, Chief Executive Officer | Award | 21,382 |
| 2025-03-04 | Davis Todd C | Director, Chief Executive Officer | Award | 93,476 |
| 2025-03-04 | Espinoza Octavio | Chief Financial Officer | Award | 7,484 |